Gilead Sciences

2 Pharma Stocks That Would Make Ideal Takeover Candidates
Seeking Alpha
Mon, 05/2/11 - 09:24 am
M&A
Gilead Sciences
Forest Labs
Gilead Q1 profit dips to $651.1M
Bizjournals.com
Wed, 04/20/11 - 07:07 pm
earnings
Gilead Sciences
Gilead Sciences signs licensing deal with MicroDose for potential respiratory virus drug
Yahoo/AP
Wed, 04/20/11 - 12:06 pm
Gilead Sciences
RSV
MicroDose Therapeutx
MDT-637
Earnings Preview: Gilead Sciences
Yahoo/Zacks.com
Tue, 04/19/11 - 11:10 am
Gilead Sciences
earnings
Gilead AIDS prevention pill study halted; no benefit seen
Yahoo/AP
Mon, 04/18/11 - 11:01 am
Truvada
AIDS
Gilead Sciences
HIV
[video] The Next Big Thing In Biotech: Earnings
TheStreet.com
Fri, 04/15/11 - 11:31 am
biotech
earnings
Amgen
Gilead Sciences
Biogen Idec
Alexion
Biotech Earnings Season Preview
Seeking Alpha
Wed, 04/13/11 - 09:16 am
biotech
earnings
Amgen
Biogen Idec
Gilead Sciences
Alexion
Biotech Stock Mailbag: Hep C Stock Winners
TheStreet.com
Fri, 04/8/11 - 10:56 am
hepatitis C
Pharmasset
Merck
Optimer
Vertex Pharmaceuticals
Gilead Sciences
JNJ
InterMune
Bristol-Myers Squibb
Gilead Sciences Raises Price Of Top Selling Products
Morningstar
Tue, 04/5/11 - 08:42 am
Gilead Sciences
drug pricing
HIV
The 15 Most-Watched Biotech Stocks
Motley Fool
Mon, 04/4/11 - 11:06 pm
Gilead Sciences
Exelixis
Amgen
Dendreon
Immunogen
Maxygen
MannKind
PDL Biopharma
Celgene
Geron
Vertex Pharmaceuticals
Arena Pharmaceuticals
Human Genome Sciences
Orexigen
Biogen Idec
Gilead's Long-Term Cancer Fight
Motley Fool
Thu, 03/31/11 - 11:51 am
Gilead Sciences
cancer
It's the Combo That Matters for Gilead
Motley Fool
Fri, 03/25/11 - 09:27 am
Gilead Sciences
Merck
Isentress
elvitegravir
Abbott Laboratories
GILD's Elvitegravir Meets Study Goal
Yahoo/Zacks
Thu, 03/24/11 - 03:06 pm
Gilead Sciences
elvitegravir
HIV
Gilead HIV drug meets study goal
Yahoo/AP
Wed, 03/23/11 - 10:28 am
Gilead Sciences
HIV
elvitegravir
Who Will Win the Hepatitis C Market?
Seeking Alpha
Mon, 03/14/11 - 10:44 am
hepatitis C
Gilead Sciences
Merck
Bristol-Myers Squibb
Novartis
Pfizer
Vertex Pharmaceuticals
Pharmasset
Gilead’s High Bar for AIDS Drugs Means New Development Withers
Bloomberg
Mon, 03/14/11 - 10:16 am
Gilead Sciences
AIDS
HIV
Merck
Bristol-Myers Squibb
Gilead Recommends Rejection of Mini-Tender Offer By TRC Capital Corporation
Sat, 03/12/11 - 01:19 pm
Gilead Sciences
Gilead Drug Combination Cut Hepatitis Virus in Study, RBC Says
Bloomberg
Tue, 03/8/11 - 07:58 am
Gilead Sciences
hepatitis C
Gilead Sciences removes warning for Letairis
Yahoo/AP
Sat, 03/5/11 - 12:05 pm
Gilead Sciences
Letairis
A Victory For Gilead
Forbes
Fri, 03/4/11 - 01:01 pm
Gilead Sciences
Myogen
HIV

Pages